Technology | November 30, 2012

TriVascular Receives FDA Approval for Ovation Abdominal Stent Graft System

Lowest profile system expands patient access to endovascular aneurysm repair (EVAR)

TriVascular Inc. Ovation Abdominal Stent Graft System Aneurism Repair

November 30, 2012 — TriVascular Inc. announced premarket approval (PMA) of the Ovation Abdominal Stent Graft System by the U.S. Food and Drug Administration (FDA) for the treatment of abdominal aortic aneurysms (AAA). Delivered through a 14 French (4.7 mm) outer diameter catheter, Ovation is the lowest profile commercially available system for EVAR. With a broader set of indications for use (IFU) than other approved systems, Ovation expands the pool of patients eligible for EVAR.

The Ovation Abdominal Stent Graft System is used instead of a more open (invasive) surgery in patients who have an abdominal aortic aneurysm. The stent system should benefit patients with an abdominal aneurysm by redirecting blood flow, preventing growth or rupture of the aneurysm.

The Ovation Abdominal Stent Graft System should not be used in patients who:

  • Are unable to undergo the necessary preoperative and postoperative imaging and implantation studies;
  • Have an infection that might threaten to infect the stent graft; and
  • Are sensitive to, or allergic to, the device materials.


The Ovation Abdominal Stent Graft System received CE mark approval in August 2010. In the United States, Ovation received the first-ever humanitarian device exemption (HDE) approval for EVAR in November 2011. To date, more than 1,000 patients worldwide have been successfully treated with the Ovation Abdominal Stent Graft System.

TriVascular is directly marketing Ovation in select European countries while actively appointing independent distributors in other international markets. With PMA approval in hand, TriVascular plans to build a direct field service organization domestically to drive patient access to Ovation in the United States.

For more information: www.trivascular.com

Related Content

News | Stent Grafts

October 9, 2019 — Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug ...

Home October 09, 2019
Home
News | Stent Grafts

October 8, 2019 — PQ Bypass Inc. announced it has received full approval of its investigational device exemption (IDE) ...

Home October 08, 2019
Home
News | Stent Grafts

July 10, 2019 — W. L. Gore & Associates Inc. (Gore) announced the first U.S. implant of the Gore Tag Conformable ...

Home July 10, 2019
Home
Technology | Stent Grafts

May 15, 2019 — W. L. Gore & Associates Inc. (Gore) announced the U.S. Food and Drug Administration (FDA) has granted ...

Home May 15, 2019
Home
News | Stent Grafts

February 14, 2019 — Abdominal aortic stent grafts will remain the largest segment in the global aortic stent graft ...

Home February 14, 2019
Home
Technology | Stent Grafts

February 7, 2019 — Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for the Valiant ...

Home February 07, 2019
Home
News | Stent Grafts

January 7, 2019 — Endologix Inc. announced that in order to ensure optimal outcomes for patients, unrestricted sales and ...

Home January 07, 2019
Home
News | Stent Grafts

July 16, 2018 — Endologix Inc. announced one-year results from the LUCY (Evaluation of FemaLes who are Underrepresented ...

Home July 16, 2018
Home
News | Stent Grafts

June 13, 2018 — Cardinal Health announced that its Incraft Abdominal Aortic Aneurysm (AAA) Stent Graft System has ...

Home June 13, 2018
Home
News | Stent Grafts

January 8, 2018 — W. L. Gore & Associates Inc. announced the first implant of the Gore Excluder Conformable AAA ...

Home January 08, 2018
Home
Subscribe Now